| Literature DB >> 30846721 |
Tannaz Ghaffarzadegan1,2, Sofia Essén3, Phebe Verbrugghe4, Nittaya Marungruang5,4, Frida Fåk Hållenius5,4, Margareta Nyman5,4, Margareta Sandahl3.
Abstract
Bile acids (BAs) are known to be involved in cholesterol metabolism but interactions between the diet, BA profiles, gut microbiota and lipid metabolism have not been extensively explored. In the present study, primary and secondary BAs including their glycine and taurine-conjugated forms were quantified in serum of Apoe-/- mice by protein precipitation followed by reversed phase ultra-high-performance liquid chromatography and QTOF mass spectrometry. The mice were fed different lingonberry fractions (whole, insoluble and soluble) in a high-fat setting or cellulose in a high and low-fat setting. Serum concentrations of BAs in mice fed cellulose were higher with the high-fat diet compared to the low-fat diet (20-70%). Among the lingonberry diets, the diet containing whole lingonberries had the highest concentration of chenodeoxycholic acid (CDCA), ursodeoxycholic acid (UDCA), tauro-ursodeoxycholic acid (T-UDCA), α and ω-muricholic acids (MCA) and tauro-α-MCA (T-α-MCA), and the lowest concentration of tauro-cholic acid (T-CA), deoxycholic acid (DCA) and tauro-deoxycholic acid (T-DCA). The glycine-conjugated BAs were very similar with all diets. CDCA, UDCA and α-MCA correlated positively with Bifidobacterium and Prevotella, and T-UDCA, T-α-MCA and ω-MCA with Bacteroides and Parabacteroides.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30846721 PMCID: PMC6405994 DOI: 10.1038/s41598-019-40272-8
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1(a) Chemical structure of different BAs (b) BAs synthesis pathway.
Figure 2Ion chromatograms of free and taurine-conjugated BAs. The intensity of each chromatogram is normalized to 100%. I) standard 10 ng/mL and II) serum sample from Apoe−/− mice fed with whole lingonberries.
Free and conjugated BAs in the serum of Apoe−/− mice (ng/mL) fed whole lingonberries and their separated soluble and insoluble fractions and the control diets.
| Bile acids | Control – Low Fat | Control – High Fat | Whole Lingonberry | Soluble Lingonberrya | Insoluble Lingonberry |
|---|---|---|---|---|---|
|
| |||||
| CA | 99.6 ± 15.0 | 90.7 ± 12.0 | 71.5 ± 7.0 | 70.0 ± 4.8 | 114.0 ± 16.2 |
| α-MCA | 13.3 ± 0.8 | 17.2 ± 0.8 | 23.8 ± 3.0††† | 13.0 ± 0.8 | 18.3 ± 1.5 |
| β-MCA | 40.3 ± 3.5 | 92.7 ± 12.8††† | 78.7 ± 6.1†† | 54.6 ± 6.7 | 81.6 ± 10.8†† |
| ω-MCA | 62.6 ± 4.9 | 100.6 ± 14.2 | 157.0 ± 25.3*†††† | 59.7 ± 2.8 | 64 ± 7.0 |
| CDCA | 27.3 ± 0.1 | 29.1 ± 0.4 | 34.5 ± 1.5*†††† | 28.0 ± 0.2 | 32.5 ± 1.3†† |
| DCA | 80.4 ± 6.0 | 116.7 ± 7.5 | 62.1 ± 16.0* | 112 ± 6.0 | 110.4 ± 13.0 |
| HDCA | 20.9 ± 0.6 | 20.4 ± 0.6 | 26.3 ± 3.4 | 19.7 ± 0.3 | 19.5 ± 0.6 |
| UDCA | 22.9 ± 0.7 | 34.6 ± 3.5 | 62.7 ± 11.2*†††† | 24.3 ± 1.5 | 35.0 ± 2.3 |
| LCA | <RL | <RL | <RL | <RL | <RL |
|
| |||||
| G-CA | 15.9 ± 0.1 | 16.2 ± 0.1 | 16.5 ± 0.2 | 15.9 ± 0.1 | 16.3 ± 0.2 |
| G-LCA | 25.2 ± 0.01 | 25.2 ± 0.01 | 25.2 ± 0.02 | 25.2 ± 0.01 | 25.2 ± 0.02 |
| G-CDCA | 19.2 ± 0.2 | 19.0 ± 0.5 | 19.5 ± 0.2 | 19.2 ± 0.6 | 19.7 ± 0.5 |
| G-DCA | 18.0 ± 0.01 | 18.2 ± 0.07 | 18.1 ± 0.05 | 18.1 ± 0.06 | 18.1 ± 0.05 |
| G-UDCA | 13.5 ± 0.02 | 13.5 ± 0.03 | 13.6 ± 0.01 | 13.6 ± 0.01 | 13.6 ± 0.01 |
|
| |||||
| T-CA | 132.2 ± 15.2 | 175.6 ± 16.7 | 99.8 ± 10.5* | 252.1 ± 31.8†† | 151.0 ± 28.9 |
| T-α-MCA | 57.3 ± 6.3 | 207.9 ± 24.8†††† | 182.6 ± 20.7†††† | 163.6 ± 18.0†† | 98.9 ± 8.1** |
| T-β-MCA | 30.3 ± 1.6 | 55.2 ± 1.8 | 66.0 ± 7.5††† | 48.2 ± 2.6 | 68.6 ± 10.8††† |
| T-UDCA | 43.1 ± 1.6 | 87.1 ± 5.7†††† | 76.3 ± 3.1†††† | 53.1 ± 2.4**** | 46.6 ± 3.3**** |
| T-CDCA | 29.0 ± 0.5 | 32.7 ± 1.1 | 30.5 ± 0.9 | 35.9 ± 3.3†† | 31.0 ± 1.2 |
| T-DCA | 36.5 ± 1.9 | 38.8 ± 2.1 | 28.6 ± 1.0**† | 36.4 ± 0.4 | 37.4 ± 2.3 |
| T-LCA | <RL | <RL | <RL | <RL | <RL |
Results are given as means ± SEM, n = 7.
Mean values were significantly different from the High Fat control group: *P < 0·05, **P < 0·01, ***P < 0·001, ****P < 0·0001 (one-way ANOVA and Dunnett’s test).
Mean values were significantly different from the Low Fat control group: †P < 0·05, ††P < 0·01, †††P < 0·001,††††P < 0·0001 (one-way ANOVA and Dunnett’s test).
a6 mice completed the study, 3 of them were outliers.
Figure 3Concentration of serum BAs in Apoe−/− mice (ng/mL) fed whole lingonberries, soluble and insoluble fractions of the same lingonberries. Mean values were significantly different between different lingonberry groups: *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 (one-way ANOVA and Tukey’s test).
Figure 4PLS loading and score scatter plots of BAs and gut microbiota. Plots illustrate correlations between BAs (purple stars) and the gut microbiota (green circles) in Apoe−/− mice fed diets containing whole lingonberries and soluble and insoluble fractions of the same lingonberries. A larger distance from the origin (0.0) shows a stronger correlation. The score scatter plot to the bottom left indicates how each mouse is placed with respect to the PLS loading and according to the groups (green = insoluble lingonberry; blue = soluble lingonberry; red = whole lingonberry).
Figure 5Strong correlation between BAs and selected microbiota in Apoe−/− mice (r-values > 0.7). X-axis represents the relative abundance of each microbiota.
Figure 6Hepatic gene expression of Nr1h4, Cyp8b1 and Nr0b2 in Apoe−/− mice fed low-fat (LF) or high-fat (HF) control diets, or HF diets supplemented with different lingonberry fractions. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 (Mann-Whitney U test).
Chemical characteristics of BAs and IS, retention time and R2 with the applied method.
| Bile acids | Formula | MW | [M –H]− | IS | Rt (min) | R2 |
|---|---|---|---|---|---|---|
|
| ||||||
| CA | C24H40O5 | 408.3 | 407.28 | GCDCA-D4 | 4.86 | 0.9980 |
| α-MCA | C24H40O5 | 408.3 | 407.28 | GCDCA-D4 | 3.13 | 0.9931 |
| β-MCA | C24H40O5 | 408.3 | 407.28 | GCDCA-D4 | 3.46 | 0.9977 |
| ω-MCA | C24H40O5 | 408.3 | 407.28 | GCDCA-D4 | 2.88 | 0.9978 |
| CDCA | C24H40O4 | 392.3 | 391.28 | DCA-D4 | 8.50 | 0.9997 |
| DCA | C24H40O4 | 392.3 | 391.28 | DCA-D4 | 8.85 | 0.9999 |
| HDCA | C24H40O4 | 392.3 | 391.28 | GCDCA-D4 | 5.50 | 0.9995 |
| UDCA | C24H40O4 | 392.3 | 391.28 | GCDCA-D4 | 5.21 | 0.9994 |
| LCA | C24H40O3 | 376.3 | 375.29 | LCA-D4 | 10.59 | 0.9955 |
|
| ||||||
| G-CA | C26H43NO6 | 465.7 | 464.3 | GCDCA-D4 | 3.03 | 0.9987 |
| G-LCA | C26H43NO4 | 433.4 | 432.31 | DCA-D4 | 9.18 | 0.9986 |
| G-CDCA | C26H43NO5 | 449.6 | 448.31 | GCDCA-D4 | 5.40 | 0.9955 |
| G-DCA | C26H43NO5 | 449.6 | 448.31 | GCDCA-D4 | 5.92 | 0.9962 |
| G-UDCA | C26H43NO5 | 449.6 | 448.31 | GCDCA-D4 | 2.99 | 0.9987 |
|
| ||||||
| T-CA | C26H45NO7S | 515.3 | 514.28 | GCDCA-D4 | 5.06 | 0.9960 |
| T-α-MCA | C26H45NO7S | 515.3 | 514.28 | GCDCA-D4 | 2.93 | 0.9977 |
| T-β-MCA | C26H45NO7S | 515.3 | 514.28 | GCDCA-D4 | 3.09 | 0.9966 |
| T-UDCA | C26H45NO6S | 499.3 | 498.29 | GCDCA-D4 | 4.92 | 0.9959 |
| T-CDCA | C26H45NO6S | 499.3 | 498.29 | DCA-D4 | 8.05 | 0.9992 |
| T-DCA | C26H45NO6S | 499.3 | 498.29 | DCA-D4 | 8.85 | 0.9995 |
| T-LCA | C26H45NO5S | 483.3 | 482.29 | LCA-D4 | 11.16 | 0.9936 |
Serum samples of rats were used for method validation.
Precision, recovery and reporting limit and signal-to-noise ratio (S/N) for each BA.
| Bile acids | Intra-assayCVs* (%) | Inter-assayCVs** (%) | Recovery (%)1000 ng/mL | Reporting limit(RL) ng/mL | S/N instandard |
|---|---|---|---|---|---|
|
| |||||
| CA | 3.2 | 2.6 | 142 | 5 | 84 |
| α-MCA | 2.8 | 23.6 | 101 | 5 | 48 |
| β-MCA | 2.9 | 17.3 | 114 | 5 | 85 |
| ω-MCA | 2.2 | 18.8 | 128 | 5 | 81 |
| CDCA | 3.4 | 38.3 | 103 | 5 | 14 |
| DCA | 4 | 19.3 | 115 | 5 | 54 |
| HDCA | 2.9 | 9.7 | 152 | 5 | 20 |
| UDCA | 3.5 | 27.3 | 95 | 5 | 24 |
| LCA | 8.9 | 10.6 | 117 | 50 | 16 |
|
| |||||
| G-CA | 3.4 | 4 | 137 | 5 | 47 |
| G-LCA | 1.7 | 31 | 78 | 5 | 22 |
| G-CDCA | 3.7 | 17.2 | 116 | 5 | 60 |
| G-DCA | 4.1 | 25 | 108 | 5 | 14 |
| G-UDCA | 2.7 | 27.6 | 103 | 5 | 19 |
|
| |||||
| T-CA | 3.6 | 14.7 | 120 | 5 | 16 |
| T-α-MCA | 4.1 | 27.5 | 111 | 5 | 61 |
| T-β-MCA | 4.1 | 17.2 | 106 | 5 | 51 |
| T-UDCA | 3.7 | 20.2 | 108 | 5 | 34 |
| T-CDCA | 3.9 | 39.5 | 90 | 5 | 37 |
| T-DCA | 4.8 | 38.7 | 86 | 5 | 50 |
| T-LCA | 10.2 | 22.7 | 124 | 10 | 14 |
Serum samples of rats were used for method validation. *(n = 3) **(n = 6).
Primer sequences used in qPCR studies.
| Gene | Forward primer | Reverse primer | Amplicon length |
|---|---|---|---|
|
| |||
| Actb | GCTTCTAGGCGGACTGTTACTGA | GCCATGCCAATGTTGTCTCTTAT | 101 bp |
| Actg | ACCAACAGCAGACTTCCAGGAT | AGACTGGCAAGAAGGAGTGGTAA | 76 bp |
| Hmbs | GAAACTCTGCTTCGCTGCATT | TGCCCATCTTTCATCACTGTATG | 101 bp |
| Hprt | CCTAAGATGAGCGCAAGTTGAA | CCACAGGACTAGAACACCTGCTAA | 86 bp |
| Rpl13a | CCTGCTGCTCTCAAGGTTGTT | TGGTTGTCACTGCCTGGTACTT | 103 bp |
| Ubc | AGGTCAAACAGGAAGACAGACGTA | TCACACCCAAGAACAAGCACA | 101 bp |
|
| |||
| cyp8b1 | CAGGAAGTTCCGTCGATTTG | GGCCCCAGTAGGGAGTAGAC | 60 bp |
| Nr0b2 | AAAGGACCAACCAATCTCCA | GGGAGTTAGTCTTTCCCATGAGT | 70 bp |
| Nr1h4 | GAAAATCCAATTCAGATTAGTCTTCAC | CCGCGTGTTCTGTTAGCAT | 106 bp |